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Introduction
The Swiss Sentinel Surveillance Network, “Sentinella”, 
(https://www.sentinella.ch) is a cooperation venture 
between a volunteer group of about 170 physicians 
scattered across Switzerland, the Swiss Federal Office 
of Public Health (FOPH), and the Institutes of the 
 universities of Lausanne (PMU, IUMSP, and IUMF), 
Bern (BIHAM), Basel (uniham-bb), Zurich (IHAM), and 
Geneva (UIGP). Initiated in 1986, its main purpose is 
to  monitor common infectious diseases, facilitate 
 research on primary health care, and serve as a tool 
for self-evaluation. A number of diseases able to be pre-
vented through vaccination (e.g., influenza, mumps, 
and pertussis) are tracked yearly, and numerous others 
(e.g., Lyme borreliosis) in a sporadic fashion. Besides 
medical conditions, some healthcare-related events 
are monitored as well, e.g., vaccinations, HIV tests, 
emergency calls, and antibiotic prescriptions.
Surveying psychiatric conditions is not yet common in 
Sentinella. In 1986, suicide attempts were tracked for 
three years, depression for two years in 1988–1989 and 
2008–2099, and eating disorder once in 2008.
In recent years, attention deficit (hyperactivity) disor-
der (ADHD) has become a growing public health con-
cern in Western societies. The demand for stimulant 
medication has risen [1], as more and more parents 
have suspected the disorder in their children. The 
 recognition of adult ADHD and the admission of 
 methylphenidate for its treatment have boosted 
this effect. The prevalence of the disorder in children 
and adults is currently estimated at about 4% for 
each  [2,3], which would amount to approximately 
250,000 affected persons in Switzerland. In light of 
these  figures, several psychiatrists have called for 
 better standards of diagnosis and treatment.
At the same time, the diagnosis of ADHD and its treat-
ment have engendered controversy. Voices from dif-
ferent segments of society – parents, doctors, and poli-
ticians – have expressed doubts regarding the reality 
of the disorder and the usefulness of stimulant medi-
cation. In extreme cases, ADHD has been referred to 
as a “Modediagnose” (a “fashionable diagnosis”), with 
pharma cological treatment considered to be a poten-
tially dangerous way of imposing social conformity on 
misbehaving children [4]. More rigorous regulation of 
prescription practice was thus called for [5].
In response to such developments, the Sentinella pro-
gram committee decided to incorporate ADHD into its 
2012 survey. The stated aim was to “show to practition-
ers how prevalent the disorder is in primary care, how 
familiar it is, and how willing and able practitioners 
are to provide care for affected children, adolescents, 
and adults”. More generally, the role of the primary 
care physician (PCP) in the management of ADHD was 
to be elucidated.
The survey was not intended to educate practitioners 
on the symptoms and diagnosis of ADHD, but to cap-
ture a snapshot of PCPs’ current practices in dealing 
with suspected cases. The survey questions focused on 
frequency, diagnosis, and treatment. In the year 2014, a 
supplementary questionnaire was mailed out in order 
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to collect additional data on physicians’ perceived 
needs and competence in handling ADHD. The com-
plete list of questions can be found in Appendix A, pub-
lished with the online version of this article on www.
sanp.ch.
In this report, we present findings from the 2012 Senti-
nella survey and the 2014 supplementary question-
naire on ADHD. Additionally, we render the original 
data publicly available to all interested parties wishing 
to conduct their own analyses (see Appendix B on 
www.sanp.ch).
Methods
Data collection
Sentinella physicians comprised general practitioners 
(GPs), internists, and pediatricians. They represented 
about 3% of all PCPs under the age of 65 years. Adult 
and child psychiatrists were not included in the 
 sample. They were, however, part of the external spe-
cialists to whom some survey questions refer. Senti-
nella  covers all of Switzerland and is divided into 
six  administrative regions, according to cantons, as 
follows: 1) GE, NE, VD, VS; 2) BE, FR, JU; 3) AG, BL, BS, 
SO; 4) LU, NW, OW, SZ, UR, ZG; 5) AI, AR, GL, SG, SH, TG, 
ZH; 6) GR, IT. The questionnaires were distributed to 
participants by the FOPH, which was also responsible 
for collecting the data. Survey responses could be re-
turned either by post or online.
The basic data unit on which participants reported 
was the consultation, defined as any contact between 
physician and patient, either in the practice or during a 
house call. This included follow-up consultations for a 
single patient, which were to constitute separate data 
points. For the ADHD survey, physicians were asked to 
report any patient presenting with an established or 
suspected diagnosis, including those suspected by the 
physician himself or herself to have ADHD, and those 
being referred by the physician to external specialists 
for further evaluation. Patients with ADHD consulting 
for reasons unrelated to the disorder were not re-
ported.
According to applicable Swiss law, ethics approval was 
not required for surveying volunteer physicians, given 
that full patient anonymity was guaranteed. 
Questions
The main questions asked were:
– How frequent does (suspected) ADHD occur in pri-
mary care?
– How frequently is ADHD diagnosed by primary care 
physicians? How frequently do PCPs refer diagnosis 
and/or treatment to specialists?
– How competent do PCPs feel about diagnosing and 
treating the disorder? How exactly do they diagnose 
and treat it?
– Do pediatricians differ from other PCPs in their 
 approach to diagnosis and treatment?
– What needs do PCPs have regarding management 
of ADHD patients?
The full set of questions can be found in the ADHD 
“module” of the 2012 survey, which is reproduced in 
Appendix A, along with the supplementary question-
naire.
Results
Frequency
In 2012, 75 physicians (37 GPs, 22 pediatricians, and 
16  internists) reported a total of 675 ADHD-related 
 consultations, 133 of which were first contacts. Over 
90% of the data originated from physicians reporting 
for Sentinella at least 9 months of the year. The supple-
mentary questionnaire was answered by 167 physi-
cians, 65 of whom were participants of the 2012 survey. 
Responses to this questionnaire will be discussed in 
the section “The physician’s view”.
Each pediatrician reported an average of 23.5 ADHD- 
related consultations (range 1–67), which was roughly 8 
times the number reported by GPs (mean 2.7, range 1–9) 
and internists (mean 3.8, range 1–13). The regional dis-
tribution of ADHD-related visits is shown in figure 1.
On average, one out of 1000 consultations (0.1%) re-
corded by Sentinella was related to ADHD. Among 
Figure 1: Distribution of ADHD-related cases by type of primary care physician and 
 geographical region. 
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pediatricians, an average of 0.5% (5 per 1000, range: 
0–46 per 1000) of consultations concerned ADHD, 
while among both GPs and internists, the figure was 
0.03%, i.e., 18 times lower (0.3 per 1000, range: 0–6). 
The  frequency of ADHD-related patient contacts also 
proved to vary by region. In particular, it was twice as 
high in the French-speaking part (1.7 per 1000) than 
in  the remaining, mostly German-speaking part of 
Switzerland (0.8 per 1000). This figure, however, does 
not directly reflect the prevalence of ADHD patients. 
It  is confounded by regional heterogeneity in the 
 number of Sentinella physicians, in the proportion of 
GPs vs. pediatricians among them, and by the fact 
that  many consultations constitute follow-up visits 
by  the same individual. A closer approximation is 
 attained via the mean number of first consultations 
(they must be for distinct patients) per GP and pedia-
trician, respectively, for each of the two parts of the 
country. Pediatricians in the French-speaking part 
had  an average of 3.6±3.2 first consultations, com-
pared  to 3.8±3.2 in the rest of Switzerland. GPs in the 
French-speaking part on  average had 1.1±1.1 first con-
sultations, compared to 0.95±1.1 elsewhere. Note that 
these  estimates may still be biased through a potential 
lack of representativeness in the sample of Sentinella 
physicians.
Male patients represented almost 80% of ADHD- 
related consultations (73% of first consultations). 
Among both genders, the majority of first contacts 
 occurred at  primary school age (7–12 years of age). 
The  gender distribution by age category among first 
consultations is shown in figure 2.
Diagnosis
In 18% (121 out of 675) of consultations, a diagnosis had 
not been made yet, whereas either the patient or the 
physician suspected ADHD. Overall, 44% of such cases 
were diagnosed by the PCP, another 46% were diag-
nosed externally, and for the remaining 10%, data was 
either missing or no diagnostic evaluation had been 
performed.
Notable differences were observed in the diagnostic 
practice between GPs and pediatricians. Only 17% (6 
out of 34) of patients with suspected ADHD consulting 
a GP were diagnosed by the GP himself or herself, 
whereas pediatricians diagnosed 54% (47 out of 87) of 
suspected cases themselves (patients remained un-
diagnosed or data is missing in 12% of consultations 
with pediatricians; see fig. 3).
Patients’ medical histories constituted the most fre-
quently named diagnostic element (45%), followed by 
questionnaires for patients (16%). Questionnaires for 
teachers and physical examinations were each indi-
Figure 2: Age and gender distribution of ADHD-related first consultations.
Figure 3: Differences between GPs and pediatricians in diagnosing patients with 
 suspected ADHD. PCP = primary care physician. GP = general practitioner.
Figure 4: Diagnostic elements used by primary care physicians.
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cated by 10% of participants. Another 7% of responses 
each concerned neuropsychological and lab tests 
(fig.  4). GPs more often based their diagnostic assess-
ments exclusively on medical history (64% of consul-
tations) than pediatricians, who used medical history 
in conjunction with patient and teacher question-
naires roughly equally often (in 25%, 22%, and 21% of 
cases, respectively).
In 554 consultations, the patient’s diagnosis was al-
ready known at the time of the consultation, but 
had  not yet been reported in the ongoing survey. Of 
these  554 diagnoses, 34% had been made by external 
specialists and 25% by PCPs. The remaining 41% of 
the  data was missing. The PCP made the diagnosis 
 either based on medical history alone (26%) or based 
on both history and psychological testing (74%).
Treatment
At most, two treatment options could be reported per 
consultation. PCPs reported the use of medication in 
85% of consultations, and that of coaching and psycho-
therapy in 41%. Pediatricians relied more on medica-
tion (88%) and coaching/psychotherapy (45%) than GPs 
(75% and 26%, respectively). Homeopathy and dietary 
adjustments were recommended very rarely (see fig. 5). 
It should be noted that these percentages are based on 
the estimates given by PCPs on each consultation, and 
are relative to the total number of such reports given, 
which was 568 out of a possible 675. Furthermore, 16% 
of the data was missing. 
External care providers relied much more on coach-
ing/psychotherapy (71% of responses) than on medica-
tion (21%). Use of neurofeedback was rare (7%), with 
 dietary adjustments and homeopathy even rarer (2% 
and 1%, respectively). In addition, 10% of cases were 
treated by other unspecified means (see fig. 6). It should 
be noted that these percentages are based on the 
 estimates given by PCPs on each consultation, and 
are relative to the total number of such reports given, 
which was 230 out of a possible 675. Therefore, 66% of 
the data was missing.
When medication was used, it was almost always stim-
ulants like methylphenidate (almost 90% of cases). 
Among the remaining choices, atomoxetine was most 
popular (7%), followed by omega-3 fatty acids and other 
compounds (see fig. 7).
GPs differed from pediatricians in their more frequent 
reports of “other”, unspecified medications (13% vs. 
7%). Use of stimulants at first consultation did not 
 differ appreciably between male (32%) and female (39%) 
patients, but showed an age- related increase from 
no use below age 7 to 30%–50% at older ages.
Figure 5: Forms of treatment administered by general  practitioners vs. paediatricians.
Figure 6: Forms of treatment administered by external care providers, as reported 
by  general practitioners / internists and pediatricians. It should be noted that 66% of the 
data was missing. 
Figure 7: Medication used to treat ADHD. FA = fatty acid.
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The physician’s view  
(supplementary questionnaire)
Overall, 31% of GPs and 96% of pediatricians (mean: 
41%) were occasionally or frequently faced with the 
subject of ADHD in their practice. That said, only 7% of 
PCPs felt competent to diagnose ADHD in any case. 
About 28% made the diagnosis occasionally, while 61% 
did not feel competent enough and referred patients 
to  external specialists. GPs generally felt less compe-
tent than pediatricians (65% vs. 38% did not feel com-
petent, 26% vs. 42% felt somewhat competent, 2% vs. 
38% felt fully competent; fig. 8).
When queried as to the reasons for diagnosing ADHD 
only rarely, participants primarily stated a lack of 
 competence (52% of PCPs). Overall, 27% considered 
the  disorder to be insufficiently well-defined, while 
 another 26% found it to be almost non-existent in 
their  own practice. The distribution of responses can 
be found in figure 9.
Roughly half of PCPs (88% of pediatricians, 40% of GPs) 
treated ADHD patients themselves. Physicians refer-
ring patients to external specialists most often did 
so  because of a perceived lack of competence (38% of 
respondents). Other reasons given were a lack of per-
mission to prescribe drugs (8%), treatment being too 
time-consuming (6%), and doubts about the usefulness 
of methylphenidate (6%) (fig. 10).
In light of the perceived lack of competence, 57% of 
physicians felt that the issue of ADHD in primary care 
deserved more attention. That said, a significant dif-
ference was observed between groups. Whereas the 
vast majority of pediatricians (88%) shared this view, 
this figure was only 52% for GPs. Leading specific needs 
for better management of ADHD included practical 
training (50% of physicians), better information on 
 differential diagnosis, practice-oriented literature, 
and testing aids (fig. 11).
Discussion
The 2012 Sentinella survey provides a first look into 
current practices of ADHD management in Swiss pri-
mary care. The broad picture that emerges conforms 
with expectations, namely that pediatricians are much 
more commonly confronted with ADHD than GPs, 
they diagnose and treat such patients themselves 
 significantly more often than GPs, and they feel more 
competent to do so than GPs. It likewise comes as no 
surprise that the diagnostic and therapeutic practices 
of pediatricians are somewhat more refined. In addi-
tion to medical and family history, they often employ 
questionnaires for diagnosis and more frequently 
 supplement drug treatment with coaching and psy-
Figure 8: Perceived competence to diagnose ADHD among primary care physicians. 
Figure 9: Reasons given by primary care physicians for diagnosing ADHD only rarely.
Figure 10: Reasons given by primary care physicians for not treating ADHD patients 
themselves. 
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chotherapy. External caregivers, to whom GPs more 
 often refer patients than pediatricians do, are even 
more strongly reliant upon coaching and psychother-
apy, most likely because psychotherapy is frequently 
the very reason for referral to external specialists. 
Most of the patients reported are in the age range of 
7–12 years, reflecting the fact that ADHD, as manifested 
in primary care, still remains a problem primarily oc-
curring in childhood. It seems plausible that children’s 
symptoms may clash more severely with the rigid 
structure of school environments that they cannot 
avoid, whereas adults are relatively free in finding oc-
cupational niches that match their profile of strengths 
and weaknesses. Further, given the fact that adult 
ADHD has only recently been recognized as a valid 
 disorder, a time lag will necessarily ensue before af-
fected adults place their symptoms in the right context 
and seek help.
There is a strong preponderance of male patients, 
 especially among children. Overall, three out of four 
consultations concern boys. This is comparable with 
published prevalence estimates [2].
PCPs from the French-speaking part of Switzerland re-
port almost twice as many ADHD-related consulta-
tions (per 1000 overall consultations) than those from 
the rest of Switzerland. This raises the question as to 
whether ADHD prevalence might be higher in that part 
of the country. While there is tentative evidence of this 
from the C-SURF study in male conscripts [6], the mean 
number of first consultations per physician differs 
only little between the French-speaking and predomi-
nantly German-speaking regions and shows signifi-
cant variation. Therefore, these results do not allow a 
conclusive interpretation.
Medication consists of psychostimulants in 9 out of 10 
consultations. PCPs use medication four times as often 
as external specialists. Most likely, this reflects com-
mon practice, wherein PCPs refer patients in need of 
psychotherapy or other non-pharmacological treat-
ments to external specialists (e.g., psychologists, psy-
chiatrists, etc.), while remaining in charge of patients’ 
drug therapy. 
Use of homeopathy and omega-3 fatty acids is negli-
gible both in private practice and the external setting. 
There are no appreciable gender differences in the 
 frequency of stimulant treatment, either in all or just 
the first consultations. This is in contrast to studies 
based on data from Swiss health insurers showing 
that  in children and adolescents, methylphenidate is 
prescribed 2–4 times more often to boys than to 
girls [7]. This discrepancy is probably accounted for by 
differences in populations sampled by the diff erent 
studies.
Stimulant treatment, however, increased with age, 
from no prescriptions under age 7 (where only off-label 
use is permitted) to relatively stable levels of 30–50% 
of first, and 50–70% of all consultations.
The most relevant insight gleaned from the supple-
mentary questionnaire is the widespread lack of com-
petence for diagnosing and treating ADHD reported 
by  PCPs. Among GPs, 70% did not feel competent to 
 diagnose the disorder, and 60% referred patients for 
external treatment, half of them for the aforemen-
tioned reason. Among pediatricians, one-third did not 
consider themselves competent to diagnose ADHD, 
and 12% referred patients for external treatment. Two 
aspects are of note here. Firstly, PCPs are not author-
ized to make a diagnosis of ADHD in adults and must 
refer patients to psychiatrists. Secondly, the admission 
of a lack of competence does not imply that PCPs do 
not act responsibly towards patients with ADHD.
The situation in other countries appears similar. GPs 
from the UK find detecting symptoms of mental ill-
ness in young people to be challenging [8], PCPs in the 
US feel uncomfortable diagnosing ADHD in adults [9], 
and US pediatricians are only moderately accurate in 
making correct ADHD diagnoses [10]. As a result, ap-
plied diagnostic criteria often differ from established 
research criteria [11]. Several studies note a lack of 
clear,  practical guidelines and the need for increased 
education and training for PCPs [10, 11, 12]. There is par-
ticular demand for services targeting adults, especially 
adolescents transitioning into adulthood and there-
fore out of child and adolescent care [11, 13].
For this reason, PCPs both in Switzerland and else-
where find themselves in the unenviable position of 
being confronted with a disorder they do not feel com-
petent dealing with and which, at the same time, lies 
at the center of a controversy regarding the use of psy-
Figure 11: Specific needs of primary care physicians with regard to managing ADHD.
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chostimulants in children. What should be done in 
such a situation?
Like their colleagues abroad, Sentinella physicians 
 express a need for better practice-oriented training, 
better information on differential diagnosis, better 
 literature, and better testing aids, and we likewise 
 advocate such a demand. A similar call for strengthen-
ing physicians’ continued education on diagnosis and 
treatment of ADHD was also made over 10 years ago 
in  a pilot study conducted in the French-speaking 
part  of Switzerland [14], which found almost twice as 
many ADHD-related consultations, compared to other 
parts of the country. Efforts are now underway to 
 increase opportunities for training and education. 
For example, the Swiss Society of Pediatrics organized 
a first series of workshops on ADHD for pediatricians 
in 2014 and 2015, and the Swiss Society for ADHD 
 followed suit with similar courses in the fall of 2015. 
The Swiss Society of Parents of Children with ADHD 
and of Adults with ADHD (ELPOS) also offers courses, 
although mostly geared towards parents and educa-
tors. In the long-term, it is hoped that diagnostic accu-
racy will be improved not only by increased  clinical 
competence, but also by less subjective  methods of 
 diagnosis, e.g., via reproducible biomarkers [15].
Due to its structure, this survey exhibits notable limi-
tations. Firstly, given that the basic unit of measure-
ment was the consultation, inferences concerning 
 patients are difficult to make. The same patient may 
occur in the records several times and cannot be 
 identified. In some cases, we have restricted analysis to 
first consultations, as these must represent distinct 
 patients, which significantly reduced sample size. 
These circumstances make it impossible to reliably 
 assess, for instance, the question of ADHD prevalence 
or the proportion of patients prescribed stimulant 
medication. Secondly, it must be borne in mind that 
 diagnoses were not established in this study. We are 
unaware how many of the patients actually met official 
ADHD criteria. Thirdly, given that the group in ques-
tion was self-selected, we are unaware to what extent 
the participating Sentinella physicians were represent-
ative of the population of Swiss GPs and pediatricians. 
Moreover, sample sizes varied considerably by region, 
making geographical comparisons unreliable. That 
said, the regional distribution of Sentinella physicians 
was similar to that of PCPs in general. Finally, compa-
rability between PCPs and external caregivers proved 
limited given that patients seen by PCPs may differ 
 systematically from those typically seen by external 
specialists (e.g., by constituting less severe cases). Data 
on such specialists (e.g., psychiatrists, child (neuro-) 
psychiatrists, or psychologists), who treat a large pro-
portion of ADHD cases, should be collected in  future 
studies. 
In conclusion, the reported lack of diagnostic and 
 therapeutic expertise in the field of ADHD reported by 
PCPs underlines the need for increased opportunities 
for practice-relevant training and education, as well as 
better testing aids. Such a call to action is explicitly 
supported by the surveyed physicians, and efforts 
to  improve the situation are underway. The goal of 
comprehensive care would be further aided by pro-
grams to educate parents, teachers, policy-makers, the 
media, and the general public, in conjunction with 
more objective diagnostic tools.
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